Lead CML researcher discusses the evolution of a groundbreaking treatment and its effect on patient survival. When imatinib (Gleevec; Novartis), the first-ever tyrosine kinase inhibitor, made its ...

David Kindness is a Certified Public Accountant (CPA) and an expert in the fields of financial accounting, corporate and individual tax planning and preparation, and investing and retirement planning.

(Alliance News) - CML Microsystems PLC on Tuesday said it swung to a pretax loss in the 2025 financial year from a profit a year ago, despite stable revenue, as it faced an impairment charge. The ...

CML Unlocks AI’s Full Potential with Enhanced Pattern Recognition, Prediction, and Real-Time Decision-Making for Defense, Autonomous Systems, and Next-Gen Computing BOULDER, Colo.--(BUSINESS ...

The survival prognosis for patients with chronic phase CML has greatly improved since the introduction of TKIs, with some studies showing life expectancy close to the general population. Nonetheless, ...

Lindsay A. Rein, MD, reviews exciting data presented at this year’s ASH meeting, focusing on chronic myeloid leukemia (CML) and the recent approval of asciminib, a novel agent for first-, second-, and ...

US regulators’ use of a speedy clearance pathway for a new frontline indication for asciminib for chronic myeloid leukemia (CML) has raised questions due to the number of medications already available ...

Novartis has picked up a new FDA approval for its chronic myeloid leukaemia therapy Scemblix that it believes is critical to unlocking the drug's blockbuster sales potential. First-in-class STAMP ...

Exactly three years after an initial FDA green light for the third-line treatment of leukemia, Novartis’ Scemblix has won an accelerated approval to treat newly diagnosed patients. Tuesday, the FDA ...

Chronic Myeloid Leukemia (CML) affects millions worldwide, including a rising number in India. Effective management involves regular BCR-ABL testing to monitor treatment progress and adapting ...

Sunrise presenter Edwina Bartholomew announced in a live segment on Friday morning that she has cancer. Bartholomew's chronic myeloid leukaemia (CML) was first diagnosed in July and she will be ...